CLDF Title
Home | Contact Us | Bookmark
Embassy of Education  
Live Events Slide Library Webcasts Abstract Library Committee Members


Beginning Date


Ending Date





Douglas T. Dieterich, MD
Director, Institute of Liver Medicine
Professor of Medicine Division of Liver Disease
Department of Medicine
Icahn School of Medicine at Mount Sinai
New York, NY

Mark Sulkowski, MD
Medical Director, Viral Hepatitis Center
Professor of Medicine
Johns Hopkins Medical Center
Baltimore, MD


Webcast must be viewed in its entirety to claim credit.

Accredited by:

This activity is provided by the Chronic Liver Disease Foundation.

This activity Supported by:

Merck & Co.

Program Overview
In this CME webcast, Drs. Dieterich and Sulkowski discuss some of the HCV clinical data presented at ID Week. The highly interactive webcast provides expert perspective in order to optimally manage your HCV and HIV/HCV infected patients and maximize patient outcomes.
Target Audience
This activity has been designed to meet the educational needs of hepatologists, gastroenterologists, infectious disease specialists, primary care providers, nurse practitioners/physician assistants and allied health care professionals by delivering a focused, educational update that highlights the most clinically relevant advances in the management of patients with HCV.
Educational Objectives
At the conclusion of this activity, participants will be able to:
Explain the current and emerging treatment options for patients with chronic hepatitis C, with an emphasis on those with HCV/HIV coinfection
Recognize the baseline factors relevant for treatment decision making in HCV and HCV/HIV coinfected patients, including potential drug: drug interactions
Develop individualized, evidence-based treatment strategies with currently approved and soon to be approved regimens in order to optimize patient outcomes
Identify barriers to the optimal management of patients with chronic hepatitis C, specifically patients with HCV/HIV coinfection
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and the Chronic Liver Disease Foundation (CLDF).

The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this online activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Off Label Disclosure Statement:
Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

It is the policy of The University of Cincinnati College of Medicine to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.

The University of Cincinnati College of Medicine assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME/CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by The University of Cincinnati College of Medicine for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The University of Cincinnati College of Medicine is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest or a commercial interest.

In accordance with the ACCME Standards, parallel documents from other accrediting bodies, The University of Cincinnati College of Medicine policy, the following disclosures have been made: The faculty for this activity have disclosed that there will be discussion about the use of products for non-FDA approved indications. All staff at the University Of Cincinnati College Of Medicine have nothing to disclose.
Learner Assurance Statement:
The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
Faculty Disclosures:
Douglas Dieterich, MD
Grants/Research Support: AbbVie, Bristol-Myers Squibb, Gilead, Janssen, Merck
Consultant: AbbVie, Bristol-Myers Squibb, Gilead, Janssen, Merck
Grant Recipient: AbbVie, Bristol-Myers Squibb, Gilead, Janssen, Merck

Mark Sulkowski, MD
Consultant: AbbVie, Bristol-Myers Squibb, Cocyrstal, Gilead, Janssen, Merck, Trek
Grant Recipient: AbbVie, Bristol-Myers Squibb, Gilead, Janssen, Merck
Advisory Board: AbbVie, Bristol-Myers Squibb, Cocyrstal, Gilead, Janssen, Merck, Trek
Planning Committee:
Lisa Pedicone, PhD - Planning Committee/Reviewer-No Relevant Relationships
Rick Ricer, MD, Professor - CME Compliance Reviewer-No Relevant Relationships
Barbara Forney, Program Manager - CME Compliance-No Relevant Relationships


Be the first to know about our latest upcoming programs and events!


Follow us

The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2022 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.